Phosphodiesterase 4 inhibitors
US7087625B2 · kind B2 · utility
7Cited by
41References
84Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2003 |
| Grant date | Aug 8, 2006 |
| Priority date | — |
| Expiry date | Jan 26, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
PDE4 inhibition is achieved by novel nitroxide compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formulas I–III:wherein A, B, D, R1, R2, R3, R7, R8, R9, R10 and R6are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.